| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.5M | -73.8% |
| SG&A Expense | $8.0M | +6.8% |
| Operating Income | -$18.7M | +60.6% |
| Pre-tax Income | -$24.5M | +35.0% |
| Income Tax | $240K | -60.8% |
| Net Income | -$24.8M | +35.4% |
| EPS (Basic) | -$1.26 | +57.4% |
| EPS (Diluted) | -$1.26 | +57.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.1M | +297.4% |
| Short-term Investments | $0 | -100.0% |
| Inventory | $0 | — |
| Current Assets | $24.8M | -3.2% |
| Total Assets | $44.6M | +69.8% |
| Current Liabilities | $17.6M | +30.2% |
| Long-term Debt | $31.2M | +178.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.8M | +31.9% |
| Capital Expenditures | $2K | -84.6% |
| Investing Cash Flow | $18.2M | -22.0% |
| Financing Cash Flow | $26.7M | +2481.3% |
| Free Cash Flow | -$26.8M | +32.0% |
| Total Liabilities |
| $48.7M |
| +49.0% |
| Stockholders' Equity | -$4.1M | +36.3% |